Graham J, Earnshaw S, Lim J, Luthra R, Borker R. Cost-effectiveness of afatinib versus erlotinib in the first-line treatment of patients with metastatic non-small cell lung cancer with EGFR Exon 19 deletion mutations. JCP. 2016 May;2(4):31-9.
Harris JR, Patel MK, Juliao PS, Suchdev PS, Ruth LJ, Were V, Ochieng C, Faith SH, Kola S, Otieno R, Sadumah I, Obure A, Quick R. Addressing inequities in access to health products through the use of social marketing, community mobilization, and local entrepreneurs in rural Western Kenya. J Popul Res. 2012;2012:470598. doi: 10.1155/2012/470598